Recently, four prospective placebo‐controlled studies have further evaluated the disease‐modifying
properties of glucocorticoids in the treatment of rheumatoid arthritis. These studies …

Objective In the 18 month “alendronate or alfacalcidol in glucocorticoid-induced
osteoporosis”-trial (STOP-trial) patients with rheumatic diseases who started glucocorticoids were …

DE NIJS GLUCOCORTICOID-INDUCED OSTEOPOROSIS cocorticoid-induced
osteoporosis needs to be optimized in future years. Further training of health care workers in …

Yearly zoledronic acid in postmenopausal osteoporosis. - Abstract - Europe PMC Sign in |
Create an account https://orcid.org Europe PMC Menu About Tools Developers Help Contact …

The aim of this review with meta-analysis was to determine if there is a rationale to use
activated forms of vitamin D 3 to treat or prevent glucocorticoid-induced osteoporosis, and to …

… Significant group × time interactions were found between RR and RN (p = 0.001), and
between NR and RN (p = 0.04), indicating a differential EP performance over time. No group × …

Background Treatment with glucocorticoids is associated with bone loss starting soon after
therapy is initiated and an increased risk of fracture. Methods We performed a randomized, …

… de Nijs … de Nijs … Fens N, de Nijs SB, Roldaan AC, Dijkers E, Zwinderman AH, Bel EH,
Sterk PJ. Successful distinction between asthma and COPD by molecular profiling of exhaled …

… Annemarie MM Vlaar a Tjerk de Nijs a Alfons GH Kessels b Fred W. Vreeling a Ania …
We expected APS patients to have a more diffusely decreased striatal FP-CIT binding rate in …

Eosinophilic inflammation in chronic obstructive pulmonary disease (COPD) is predictive for
responses to inhaled steroids. We hypothesised that the inflammatory subtype in mild and …